Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Allergan Inc
Allergan Inc And Baylor College Of Medicine
Allergan Inc_20100107
Allergan Inc_20100121
Allergan Inc_20131212
Allergan Inc_20100114
  

Allergan Inc patents

Recent patent applications related to Allergan Inc. Allergan Inc is listed as an Agent/Assignee. Note: Allergan Inc may have other listings under different names/spellings. We're not affiliated with Allergan Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Allergan Inc-related inventors




Date Allergan Inc patents (updated weekly) - BOOKMARK this page
12/07/17Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
11/30/17Production of rounded salt particles
11/30/17Animal product free system and process for purifying a botulinum toxin
11/16/17Fusion proteins and methods for treating, preventing or ameliorating pain
11/16/17Process and system for obtaining botulinum neurotoxin
11/09/17Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
10/26/17Complement component c5 antibodies
10/19/17Ester prodrugs of gamma-lactams and their use
10/12/17Device and making a variable surface breast implant
10/12/17Aspiration and injection device
10/05/17Immuno-based botulinum toxin serotype a activity assays
09/21/17Methods of treatment of acne vulgaris using topical dapsone compositions
09/21/17Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
09/21/17Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
09/14/17Bladder injeciton paradigm for administration of botulinum toxins
09/07/17Patent alert system
08/31/17Immuno-based retargeted endopeptidase activity assays
08/17/17Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using a1-adrenoceptor agonists
08/10/17Botulinum toxin compositions
08/10/17Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
08/10/17Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
08/03/17Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
08/03/17Dermal filler
08/03/17Cells useful for immuno-based botulinum toxin serotype a activity assays
07/27/17Two part formulation system for ophthalmic delivery
07/06/17Androgen composition for treating an opthalmic condition
06/29/17Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
06/29/174-pregenen-11beta-17-21-triol-3,20-dione derivatives
06/29/17Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
06/29/17Novel ep4 agonists as therapeutic compounds
06/29/17Carbamoyl hydrazine derivatives as formyl peptide modulators
06/22/17D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders
06/22/17D-serine for the treatment of visual system disorders
06/22/17Methods of treating alpha adrenergic mediated conditions
06/22/17Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
06/22/17Botulinum toxin treatments of neurological and neuropsychiatric disorders
06/22/17Multi-site injection system
06/22/17Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
06/22/17Porogen compositions, methods of making and uses
06/08/17Method of treating conditions of the eye with an anti-vegf darpin
06/01/17Stabilized oxymetazoline formulations and their uses
06/01/17Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
06/01/17Dry dermal filler compositions and methods of reconstitution
06/01/17Novel prostamides for the treatment of glaucoma and related diseases
05/25/17Method of treating conditions with kinase inhibitors
05/25/17Compounds and methods for skin repair
05/25/17Cyclosporin compositions
05/25/17Therapeutic substituted cyclopentanes
05/18/17Botulinum toxin administration for treatment of neurogenic detrusor overactivity associated urinary incontinence
05/18/17Dermal filler compositions including antioxidants
05/18/17Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
05/11/17Methods for treating headache
05/04/17Methods of treatment of acne vulgaris using topical dapsone compositions
05/04/17Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators
04/27/17Hypotensive lipid and timolol compositions and methods of using same
04/20/17Pyridyl benzothiophenes as kinase inhibitors
04/20/17Heavy chain only antibodies to ang-2
04/13/17Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
04/06/17Imidazole derivatives as formyl peptide receptor modulators
04/06/17Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
04/06/17Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation
03/30/17Topical dapsone and dapsone/adapalene compositions and methods for use thereof
03/30/17Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof
03/30/17Bioerodible matrix for tissue involvement
03/23/17Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
Patent Packs
03/23/17Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form
03/23/17Quaternary ammonium alkyl esters as stable prodrugs
03/16/17Reinforced prosthetic implant with flexible shell
03/16/17Intracameral sustained release therapeutic agent implants
03/16/17Dapsone to treat rosacea
03/16/17Microsphere drug delivery system for sustained intraocular release
03/09/17Compositions & methods for lowering intraocular pressure
03/09/17Hypotensive lipid-containing biodegradable intraocular implants and related implants
03/09/17Compounds as tyrosine kinase modulators
03/02/17Conditioned cell culture medium compositions and methods of use
03/02/17Sustained drug delivery implant
03/02/17Prostamide-containing intraocular implants and methods of use thereof
03/02/17Substituted arylcyclopentenes as therapeutic agents
02/23/17Lighter weight implant
02/23/17Sulfur derivatives as chemokine receptor modulators
Patent Packs
02/16/17Methods for treatment of incontinence associated with sexual activity
02/16/17Heavy chain only antibodies to pdgf
02/09/17Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
02/02/17Medical device with anti adhesive property
02/02/17Silk medical devices
02/02/17Cyclosporin analogs
01/26/17Soft filled prosthesis shell with variable texture
01/26/17Therapeutic methods using cyclosporine components
01/26/17Method for treating premature ejaculation with a botulinum neurotoxin
01/26/17Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
01/12/17Methods for treatment of pelvic pain and/or comorbid conditions
01/05/17Mechanisms for injection and dosing
12/22/16Non-cytotoxic protein conjugates
12/15/16Cross linked silk-hyaluronic acid composition
12/08/16Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
12/08/16Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
12/08/16Enhanced bimatoprost ophthalmic solution
12/08/16Benzimidazole derivatives as selective blockers of persistent sodium current
12/08/16Compounds as tyrosine kinase modulators
12/01/16(-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its production and use
11/24/162,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
11/24/16Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
11/24/16Therapeutic agents for ocular hypertension
11/17/16Urea hydantoin derivatives as formyl peptide modulators
11/10/16Soft filled prosthesis shell with discrete fixation surfaces
11/10/16Hypotensive lipid-containing biodegradable intraocular implants and related methods
11/03/16Self-sealing shell for inflatable prostheses
11/03/16Methods for fat reduction
11/03/16Methods of intracellular conversion of single-chain proteins into their di-chain form
10/27/16Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
Social Network Patent Pack
10/27/16Prostamides for enhancement of leptin production
10/27/16Dermal filler compositions for fine line treatment
10/27/16Compositions containing alpha-2-adrenergic agonist components
10/20/16Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole derivatives for treating retinal diseases
10/20/16Methods and devices for desmopressin drug delivery
10/06/16Cyclosporins modified on the mebmt sidechain by heterocyclic rings
09/29/16Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
09/29/16Dermal filler compositions including antioxidants
09/29/16Dissolvable microneedles for skin treatment
09/22/16Autoclavable suspensions of cyclosporin a form 2
Patent Packs
09/22/16Phenylcarbamate derivatives as formyl peptide receptor modulators
09/22/16Cyclosporin a form 2 and making same
09/15/16Hypotensive lipid-containing biodegradable intraocular implants and related implants
09/15/16Injection paradigm for administration of botulinum toxins
09/15/16Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde 10a)
09/08/16Sustained-release reservoir implants for intracameral drug delivery
09/08/16Ophthalmic compositions and methods for treating eyes
09/01/16Enhanced bimatoprost ophthalmic solution
08/25/16Steroid-containing sustained release intraocular implants and related methods
08/25/16Topical dapsone and dapsone/adaplene compositions and methods for use thereof
08/25/16Ketorolac tromethamine compositions for treating or preventing ocular pain
08/25/16Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
08/18/16Two part formulation system for ophthalmic delivery
08/18/16Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators
08/18/16Eye drop formulation with enhanced properties by combining sodium hyaluronate with carboxymethylcellulose
08/11/16Compositions and methods for hair growth
08/11/16Ophthalmic compositions and methods for treating ophthalmic conditions
08/11/16Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
08/04/16Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
07/28/16Silk medical device
07/28/16Prosthetic device and manufacturing the same
07/28/16Mechanical syringe accessory
07/21/16Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
07/14/16Compositions and methods for stimulating hair growth
07/14/16Biodegradable intravitreal tyrosine kinase implants
07/14/16Prostamide-containing intraocular implant
07/14/16Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
07/14/16Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
07/14/16Degradable clostridial toxins
07/07/16Pliable silk medical device
Patent Packs
07/07/16Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
07/07/16Substituted nicotinamide derivatives as kinase inhibitors
06/30/16Compositions containing aromatic aldehydes and their use in treatments
06/23/16Method of enhancing hair growth
06/23/16Method of enhancing hair growth
06/23/16Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof
06/23/16Injection paradigm for administration of botulinum toxins
06/23/16Sustained release poloxamer containing pharmaceutical compositions
06/16/16Stabilization of therapeutic agents to facilitate administration
06/09/16Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
06/09/16Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
06/09/16Syringe assembly
06/02/16High recovery vial adaptor
06/02/16Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
06/02/16Suture line administration technique using botulinum toxins
06/02/16Porogen compositions, methods of making and uses
05/26/16Stabilized omega-3 ophthalmic compositions
05/26/16Methods of providing therapeutic effects using cyclosporin components
05/26/16Syringe extrusion accessory
05/26/16Fat processing system
Social Network Patent Pack
05/19/16Bicyclic 1,3,4-oxadiazole derivatives as sphingosine-1-phosphate receptors' modulators
05/12/16Suspensions of cyclosporin a form 2
05/05/16Method for improving duration of effect of dermal filler treatment
05/05/16Drug eluting silicone gel sheeting for wound healing and scar reduction
04/28/16Preservative free bimatoprost and timolol solutions
04/28/16Injection device and diluting an injectable fluid
04/14/16Methods for sterilizing compositions and resulting compositions
04/14/16Indole-3-carboxamides as kinase inhibitors
04/14/16Pyridyl benzothiophenes as kinase inhibitors
04/14/16Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
04/14/16Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2
04/07/16Silk fibroin hydrogels and uses thereof
04/07/16Devices for injection and dosing
04/07/16Treatment of inflammatory bowel disease
04/07/16Indole-1-carboxamides as kinase inhibitors
04/07/16Kinase inhibitors
04/07/16Substituted 1,2,3,4-tetrahydropyrido[3,4-e] pyrrolo[1,2-a]pyrimidines as kinase inhibitors
04/07/16Process and system for obtaining botulinum neurotoxin
03/31/16Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
03/31/16Compounds as tyrosine kinase modulators
Social Network Patent Pack
03/24/16Compositions for enhancing nail health
03/24/16Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using a1-adrenoceptor agonists
03/24/16Sulfur derivatives as chemokine receptor modulators
03/24/161-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
03/24/16Crystalline form of cyclosporin a, methods of preparation, and methods for use thereof
03/17/16Inflatable prostheses and methods of making same
03/17/16Ocular implant made by a double extrusion proces
03/17/16Methods for treating osteoarthritis pain
03/10/16Compounds as tyrosine kinase modulators
03/10/16Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
03/10/16Method for treating premature ejaculation with a botulinum neurotoxin
03/10/16Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
03/03/16Methods for treating scars and aging skin
03/03/16Methods for treating scars and aging skin
02/25/16Comparative efficacy and tolerability of dapsone 5% in adult versus adolescent females with acne vulgaris
02/25/16Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8- tetrahydro-quinoline for treating skin diseases and conditions
02/25/16Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
02/18/16N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
02/11/16Prosthetic fabric structure
02/11/16Dermal filler
02/11/16Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
02/11/16Sustained release intraocular implants and methods for treating ocular vasculopathies
02/11/16Muscarinic agonists
02/11/16Cyclosporin a analogs
02/04/16Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
02/04/16Formulations of biologics for intravesical instillation
02/04/16Topical dapsone and dapsone/adaplene compositions and methods for use thereof
01/28/16Processes for making cyclic lipid implants for intraocular use
01/28/16Cyclosporin analogs
01/28/16Porous materials, methods of making and uses
Social Network Patent Pack
01/28/16Compounds and methods for treating ocular diseases
01/21/16Suspension compositions of cyclosporin a for subconjunctival and periocular injection
01/21/16Enhanced bimatoprost ophthalmic solution
01/21/16Oil-in-water making polymeric implants containing a hypotensive lipid
01/14/16Sustained release intraocular implants and methods for preventing retinal dysfunction
01/14/16Methods for treatment of incontinence associated with sexual activity
01/07/16Method of detecting cleaved snap25 in tissue samples
12/31/15Devices and methods for sustained treatment of bladder pain and irritative voiding
12/31/15Laterally connected syringes with integrated mixing hub and static mixer
12/31/15Tromethamine salt of bimatoprost acid in crystalline form 1, methods for preparation, and methods for use thereof
12/24/15Method of treating allergic conjunctivitis with cyclosporin compositions
12/24/15Androgen composition for treating an opthalmic condition
12/17/15Stabilized oxymetazoline formulations and their uses
12/10/15Silk medical device for use in breast augmentation and breast reconstruction
12/10/15Sustained release poloxamer containing pharmaceutical compositions
12/10/15Dermal filler compositions including antioxidants
12/03/15Cyclosporin compositions
12/03/15Methods for reducing the occurrence or preventing formation of bladder calculi
12/03/15Injection device
11/26/15Amidoalkylenyl and amidoaryl esters, compositions thereof, and methods for their use
11/26/15Therapeutic substituted pyrroles
11/19/15Textured breast implant and methods of making same
11/19/15Soft filled prosthesis shell with variable texture
11/19/15Compositions and methods for stimulating hair growth
11/19/15Compounds for protection of photoreceptor cells and for enhancing visual function under low light conditions
11/19/15High force injection devices
11/19/15Therapeutic prostaglandin receptor agonists
11/12/15Method of enhancing hair growth
11/12/15Retinoid topical compositions and methods for treating skin conditions







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Allergan Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Allergan Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';